The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections-Reference-Cited by-同舟云学术

The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections

Published:2019-02 Issue:2 Volume:25 Page:111-116
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Mikamo Hiroshige^ORCID,Monden Kazuteru,Miyasaka Yoshiaki,Horiuchi Tetsuya,Fujimoto Go,Fukuhara Takahiro,Yoshinari Tomoko,Rhee Elizabeth G.,Shizuya Toshiyuki

Funder

Pfizer Japan Inc.

MSD K.K.

Taisho Toyama Pharmaceutical Co., Ltd.

Daiichi-Sankyo Co., Ltd.

Astellas Pharma Inc.

Sumitomo Dainippon Pharma Co., Ltd.

Shionogi & Co., Ltd.

Miyarisan Pharmaceutical Co. Ltd.

Meiji Seika Pharma Co., Ltd.

Fujifilm Pharma Co., Ltd

Toyama Chemical Co., Ltd.

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference11 articles.

1. Guidance for Industry-Complicated Intra-Abdominal Infections: Developing Drugs for Treatment;Clin Antimicrob,2015

2. Mortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infection;Inui;Surgery,2009

3. Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria;Herzog;Eur J Med Res,2010

4. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs;Sturkenboom;Br J Clin Pharmacol,2005

5. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America;Solomkin;Clin Infect Dis,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On the assessment of the role of new antibiotics in pharmacotherapy algorithms for complicated intra-abdominal infections (literature review);Journal of Volgograd State Medical University;2024-08-05

2. Friends or foes? Novel antimicrobials tackling MDR/XDR Gram-negative bacteria: a systematic review;Frontiers in Microbiology;2024-05-10

3. Challenges and Emerging Molecular Approaches in Combating Antimicrobial Resistance;Journal of Bacteriology and Virology;2024-03-31

4. Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence;Future Microbiology;2024-01-22

5. Epidemiological analysis and antimicrobial susceptibility profile of Gram-negative bacilli that cause bacteremia in Japan;Journal of Infection and Chemotherapy;2023-12